Discontinuation report PMS-LOSARTAN-HCTZ
| Report ID | 53201 |
| Drug Identification Number | 02392240 |
| Brand name | PMS-LOSARTAN-HCTZ |
| Common or Proper name | LOSARTAN |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
| Strength(s) | 25MG 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-06-29 |
| Remaining supply date | 2018-06-29 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | PRODUCT IN DEACTIVATION PROCESS |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-06-30 | English | Compare |
| v2 | 2018-06-29 | French | Compare |
| v1 | 2018-06-29 | English | Compare |
Showing 1 to 3 of 3